Intraventricular Catheter

Its ventricular placement creates a direct pathway to cerebrospinal fluid, allowing investigators to move fluids, therapeutic agents, or samples between the brain ventricle and an external connection. This controlled access supports repeated or carefully managed delivery and collection, making it possible to study treatment exposure and fluid-based biological signals within the central nervous system.

A reservoir or external device provides the connection through which material can move after the catheter reaches the ventricular system. Depending on the research objective, that connection can support administration of a drug or experimental treatment, collection of cerebrospinal fluid, or both. The configuration therefore links ventricular access with controlled intervention and analysis.

Ventricular access helps researchers examine treatment delivery within the central nervous system, where effective therapy can be difficult to achieve. In studies of brain tumors and leptomeningeal disease, it supports investigation of drug distribution, experimental treatment activity, and treatment response. These measurements help address how therapies reach relevant disease sites and how their effects can be evaluated.

Cancer researchers can use this approach to investigate intrathecal chemotherapy, targeted agents, and experimental treatments. Delivering these interventions through cerebrospinal fluid allows studies to focus on therapy within the central nervous system rather than relying only on approaches that do not directly access the ventricular fluid. The method is therefore relevant to treatment development for brain-associated cancer.

The catheter is placed into the ventricular system through a neurosurgical opening and then connected to a reservoir or external device when needed. Researchers can subsequently introduce a treatment or collect cerebrospinal fluid through that access route. The resulting workflow links neurosurgical placement with controlled administration or sampling for a defined cancer research question.

Collected cerebrospinal fluid can be analyzed for tumor-associated biomarkers, providing biological information relevant to disease investigation. Researchers can use these samples alongside treatment studies to examine disease-associated signals, evaluate treatment response, and explore how therapies behave in the central nervous system. This makes fluid collection an important complement to direct therapeutic delivery.